Vnitr Lek 2010, 56(11):1116-1121

A different view of acute upper gastrointestinal bleeding in liver cirrhosis patients

P. Svoboda1,*, J. Ehrmann2, P. Klvaňa1, E. Machytka1, M. Rydlo1, V. Hrabovský1
1 Interní klinika FN Ostrava, přednosta doc. MUDr. Arnošt Martínek, CSc.
2 II. interní klinika Lékařské fakulty UP a FN Olomouc, přednosta doc. MUDr. Vlastimil Procházka, Ph.D.

Objectives:
The study focuses predominantly on non-varicose sources of acute upper gastrointestinal bleeding in liver cirrhosis patients and aims to determine its mortality.


Methods and subjects:
The prospective examination included 137 liver cirrhosis patients with acute upper GIT bleeding. All the patients underwent an endoscopic examination. In case of multiple findings, defining the bleeding source was based on the specialist's attitude presented as the conclusion of the endoscopic examination.

Results:
The most frequent causes of acute bleeding included oesophagus varices (57.7%), followed by peptic gastric and duodenal ulcers (18.2%), then portal hypertension gastropathy (9.5%), gastric varices (5.1%), reflux oesophagitis (2.9%), Mallory-Weiss syndrome (2.9%) and erosive gastropathy (1.5%). The endoscopy of the upper digestive tract resulted in a negative diagnosis in not more than 2.2% of patients. The majority of examinations showed multiple findings in the upper digestive tract, each of which could have been a potential cause of bleeding. Mortality in all bleeding cirrhotic patients reached 14.6%, 18.6% of which were related to the varicose type of bleeding and 7.8% to the non-varicose type.

Conclusion:
Portal hypertension led to bleeding (caused by varices and portal hypertension gastropathy) in 72.3% of patients, 62.8% patients suffered from purely varicose bleeding, 37.2% patients from non-varicose bleeding. Mortality was statistically significantly higher on 0.1 level of significance in cases of varicose bleeding in comparison with non-varicose bleeding. An emphasis should be laid on an early and detailed endoscopic examination leading to an appropriate diagnosis and therapy.

Keywords: liver cirrhosis; portal hypertension; acute bleeding; peptic ulcer; endoscopy

Received: April 7, 2010; Accepted: July 8, 2010; Published: November 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Svoboda P, Ehrmann J, Klvaňa P, Machytka E, Rydlo M, Hrabovský V. A different view of acute upper gastrointestinal bleeding in liver cirrhosis patients. Vnitr Lek. 2010;56(11):1116-1121.
Download citation

References

  1. Lata J. Portální hypertenze při jaterní cirhóze a její důsledky. Plzeň: GAAN CZ 2000.
  2. Husová L, Juránková J, Lata J et al. Bakteriální infekce ve vztahu ke vzniku a průběhu varikózního krvácení. Vnitř Lék 2007; 53: 1255-1264. Go to PubMed...
  3. Cameron EA, Pratap JN, Sims TJ et al. Three-year prospective validation of a pre-endoscopic risk stratification in patients with acute upper-gastrointestinal haemorrhage. Eur J Gastroenterol Hepatol 2002; 14: 497-501. Go to original source... Go to PubMed...
  4. D'Amico G, De Franchis R. Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38: 599-612. Go to original source... Go to PubMed...
  5. Odelowo OO, Smoot DT, Kim K. Upper gastrointestinal bleeding in patients with liver cirrhosis. J Natl Med Assoc 2002; 94: 712-715. Go to PubMed...
  6. Fassio E, Viudez P, Landeira G. Upper digestive hemorrhage in liver cirrhosis: clinical and endoscopic findings. Acta Gastroenterol Latinoam 1992; 22: 181-186. Go to PubMed...
  7. Gostout CJ, Viggiano TR, Balm RK. Acute gastrointestinal bleeding from portal hypertensive gastropathy: prevalence and clinical features. Am J Gastroenterol 1993; 88: 2030-2033.
  8. Seo YS, Kim ZH, Ahn SH et al. Clinical features and treatment outcomes of upper gastrointestinal bleeding in patients with cirrhosis. J Korean Med Sci 2008; 23: 635-643. Go to original source... Go to PubMed...
  9. Kantorová I, Svoboda J, Ochmann J et al. Duplicita zdroje krvácení u pacientů s jícnovými varixy. Rozhl Chir 1997; 76: 543-547. Go to PubMed...
  10. Zaman A, Hapke R, Flora K et al. Prevalence of upper and lower gastrointestinal tract findings in liver transplant candidates undergoing screening endoscopic evaluation. Am J Gastroenterol 1999; 94: 895-899. Go to original source... Go to PubMed...
  11. Hashizume M, Tanaka K, Inokuchi K. Morphology of gastric microcirculation in cirrhosis. Hepatology 1983; 3: 1008-1012. Go to original source... Go to PubMed...
  12. Sarfeh IJ, Soliman H, Waxman K et al. Impaired oxygenation of gastric mucosa in portal hypertension. The basis for increased susceptibility to injury. Dig Dis Sci 1989; 34: 225-228. Go to original source... Go to PubMed...
  13. Svoboda P, Ehrmann J, Klvaňa P et al. Hepatogenní vřed. Čes a Slov Gastroent a Hepatol 2007; 61: 249-253.
  14. Siringo S, Burroughs AK, Bolondi K et al. Peptic ulcer and its course in cirrhosis: an endoscopic and clinical prospective study. J Hepatol 1995; 22: 633-641. Go to original source... Go to PubMed...
  15. Thomas E, Rosenthal WS, Rymer W et al. Upper gastrointestinal hemorrhage in patients with alcoholic liver disease and esophageal varices. Sources, outcome and short-term impact on liver function. Am J Gastroenterol 1979; 72: 623-629.
  16. Svoboda P, Ehrmann J, Klvaňa P et al. Endoskopické nálezy v horním trávicím traktu u pacientů s jaterní cirhózou. Vnitř Lék 2007; 53: 968-971. Go to PubMed...
  17. Machytka E, Ehrmann J, Svoboda P et al. Dlouhodobé sledování pacientů s klinickými známkami krvácení do horní části trávicího traktu a negativním endoskopickým nálezem. Vnitř Lék 2007; 53: 942-946. Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.